THE ROCKET HITS A CEILING: Crowd Rules SpaceX Stays Below $200, Even After It Already Broke Through Once

They told you it was the future. They rang the opening bell, fired up the hype machine and sold you a ticket to Mars at Wall Street prices. Now the people have looked at that ticket and given their answer: below $200. In the opinion markets on Morfi, where people put real money behind what they believe, the first verdict on the SpaceX share price is in, and it doesn't flatter the launchpad.

Look at the record. According to NPR, the company listed on Nasdaq under the ticker SPCX in June 2026, priced at one hundred thirty-five dollars a share in the largest IPO on record, and closed its first day at nearly one hundred sixty-one dollars. Then came the twist. NPR reported that the stock touched an intraday high above two hundred twenty-five dollars, only to close at about one hundred twenty-five by the first earnings report in early August. That's below the price the insiders charged everyone else. Revenue nearly doubled to roughly seven point eight billion dollars for the quarter, but the company still lost more than half a billion. And a lock-up expiry was set to more than double the number of tradable shares, which analysts flagged as a source of selling pressure.

And the valuation? Morningstar put the company at about seven hundred eighty billion dollars and called it significantly overvalued, according to the Wikipedia account of the offering. It also noted that a public float of only around five percent of shares could prop up the price early on. A tiny float, a giant price tag and a wall of insider shares waiting to unlock: that isn't a market, it's a velvet rope. Note that the latest price data dates from early August, so where SPCX trades today is unconfirmed.

Here is the crowd's ruling. Below $200 leads with 65% consensus. At or above $200 trails at 35%. It's a straight two-way fight, with 16 traders putting $30,352 behind their convictions, and trading opened less than a day ago. These numbers measure conviction, not a headcount, and the conviction leans clearly toward the ceiling holding. The crowd has seen the spike above $200 and the crash back under the IPO price, and it's betting on the crash being the real story.

My take, and it is an opinion, delivered at full volume: good. Why should the richest man on Earth, Elon Musk, get a fairy-tale valuation for a company that still loses money every quarter? Why should a five percent float, engineered scarcity dressed up as opportunity, decide what everyone else pays? The IPO machine works the same way every time. Insiders price it, the hype lifts it, retail buys the top, and then the lock-up opens the exit for the people who were in first. The crowd on Morfi sees the trick and won't clap for it. That isn't pessimism about rockets. It's a refusal to keep paying the toll on the elevator.

What to watch next: the lock-up shares hitting the market, the next earnings report, and whether that loss column ever shrinks. If the supply flood comes and the price holds, the challengers will roar back. If it doesn't, the ceiling hardens into concrete. The verdict is young and the market is live, so join it on Morfi and put your money where your conviction is.